IDEXX LABORATORIES INC /DE Proceeds from Issuance of Senior Long-term Debt
IDEXX LABORATORIES INC /DE (IDXX) reported Proceeds from Issuance of Senior Long-term Debt of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt · last filed 2023-02-16
- IDEXX LABORATORIES INC /DE proceeds from issuance of senior long-term debt for the quarter ending 2021-12-31 was $0.00.
- IDEXX LABORATORIES INC /DE proceeds from issuance of senior long-term debt for the quarter ending 2021-09-30 was $0.00.
- IDEXX LABORATORIES INC /DE proceeds from issuance of senior long-term debt for the quarter ending 2020-12-31 was $0.00.
- IDEXX LABORATORIES INC /DE proceeds from issuance of senior long-term debt for the quarter ending 2020-09-30 was $0.00.
- IDEXX LABORATORIES INC /DE proceeds from issuance of senior long-term debt for fiscal 2022 was $0.00.
- IDEXX LABORATORIES INC /DE proceeds from issuance of senior long-term debt for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- IDEXX LABORATORIES INC /DE proceeds from issuance of senior long-term debt for fiscal 2020 was $200.00M, a 100.00% increase from fiscal 2019.
- IDEXX LABORATORIES INC /DE proceeds from issuance of senior long-term debt for fiscal 2019 was $100.00M.
| Period end | Proceeds from Issuance of Senior Long-term Debt 3 month | Proceeds from Issuance of Senior Long-term Debt 6 month | Proceeds from Issuance of Senior Long-term Debt 9 month | Proceeds from Issuance of Senior Long-term Debt 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-02-16 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $0.00 derived: sum of 2 quarters · filed 2023-02-16 | $0.00 10-K · filed 2023-02-16 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $0.00 10-Q · filed 2021-11-02 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-07-30 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $0.00 derived: sum of 2 quarters · filed 2023-02-16 | $200.00M derived: sum of 3 quarters · filed 2023-02-16 | $200.00M 10-K · filed 2023-02-16 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $200.00M derived: sum of 2 quarters · filed 2021-11-02 | $200.00M 10-Q · filed 2021-11-02 | $200.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $200.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $200.00M 10-Q · filed 2021-07-30 | $200.00M derived: sum of 3 quarters · filed 2022-02-16 | $200.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | $0.00 10-Q · filed 2020-04-30 | $0.00 derived: sum of 2 quarters · filed 2022-02-16 | $0.00 derived: sum of 3 quarters · filed 2022-02-16 | $0.00 derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $0.00 derived: sum of 2 quarters · filed 2022-02-16 | $0.00 derived: sum of 3 quarters · filed 2022-02-16 | $100.00M 10-K · filed 2022-02-16 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $0.00 derived: sum of 2 quarters · filed 2020-10-29 | $100.00M 10-Q · filed 2020-10-29 | $100.00M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $100.00M 10-Q · filed 2020-07-31 | $100.00M derived: sum of 3 quarters · filed 2021-02-12 | $100.00M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-03-31 | $100.00M 10-Q · filed 2020-04-30 | $100.00M derived: sum of 2 quarters · filed 2021-02-12 | $100.00M derived: sum of 3 quarters · filed 2021-02-12 | $100.00M derived: sum of 4 quarters · filed 2021-02-12 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $0.00 derived: sum of 2 quarters · filed 2021-02-12 | $0.00 derived: sum of 3 quarters · filed 2021-02-12 | $0.00 10-K · filed 2021-02-12 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $0.00 derived: sum of 2 quarters · filed 2019-10-31 | $0.00 10-Q · filed 2019-10-31 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-01 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-14 | |||
| 2015-12-31 | $250.10M 10-K · filed 2018-02-16 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $200.00M 10-K · filed 2017-02-17 | ||
| 2014-09-30 | $200.00M 10-Q · filed 2014-10-24 | |||
| 2013-12-31 | $150.00M 10-K · filed 2016-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |